Indian Institute of Public Health-Delhi, Public Health Foundation of India, Gurgaon, India.
J Health Serv Res Policy. 2024 Apr;29(2):76-83. doi: 10.1177/13558196231215969. Epub 2023 Nov 23.
Cervical cancer accounts for 10 percent of cancer deaths among women in India. The human papillomavirus (HPV) vaccine can protect against infection but it is not included in India's universal immunisation programme. This study aimed to assess the demand and willingness to pay for the HPV vaccine among mothers of adolescent daughters.
We conducted a contingent valuation exercise involving a hospital-based cross-sectional study to assess the demand for an HPV vaccine among mothers of adolescent daughters, their willingness to pay and its determinants. Participants were recruited at a tertiary care civil hospital in the city of Gurgaon in North India, and data was collected from December 2018 to February 2019. A questionnaire was administered to obtain demographic and awareness indicators. Payment cards were used to elicit the willingness to pay amount.
Out of 319 respondents, 79% were willing to pay for the vaccine. The mean maximum willingness to pay was INR 629 (USD 35), which was less than the vaccine market price of INR 2000-3000 (USD 117-175) per dose. Participant age and number of children significantly influenced demand, while family income and awareness of cervical cancer influenced willingness to pay for the HPV vaccine. Participants were willing to spend between 3% and 34% of their monthly income on the vaccine.
High demand and low willingness to pay for the HPV vaccine indicate low value perception of the health outcome among mothers of adolescent children in India. A strategy aimed at a price reduction of the vaccine and increasing its demand through improved awareness is important. At the same time, subsidising the vaccine in the short run is needed.
在印度，宫颈癌导致的女性癌症死亡人数占 10%。人乳头瘤病毒（HPV）疫苗可以预防感染，但它并未被纳入印度的全民免疫计划。本研究旨在评估印度青少年女性母亲对 HPV 疫苗的需求和支付意愿。
我们进行了一项基于意愿的评估，采用基于医院的横断面研究，以评估青少年女性母亲对 HPV 疫苗的需求、她们的支付意愿及其决定因素。研究对象招募自印度古尔冈市的一家三级护理公立医院，数据收集于 2018 年 12 月至 2019 年 2 月期间。通过问卷调查获取人口统计学和意识指标，使用支付卡来获取支付意愿金额。
在 319 名受访者中，79%的人愿意为疫苗付费。最大平均支付意愿为 INR629（USD35），低于 HPV 疫苗市场价格 INR2000-3000（USD117-175）/剂。参与者年龄和子女数量显著影响需求，而家庭收入和对宫颈癌的认识影响 HPV 疫苗的支付意愿。参与者愿意将其月收入的 3%至 34%用于购买疫苗。
对 HPV 疫苗的高需求和低支付意愿表明，印度青少年女性母亲对健康结果的价值认知较低。重要的是，需要制定一项旨在降低疫苗价格并通过提高认识来增加其需求的策略。同时，在短期内需要补贴疫苗。
